Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Indole-2-carboxylic acid | HCID 72899 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | HCID 54424075 | HCID 54424075 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 86752407 | HCID 86752407 | — |
Reaction Steps
To a solution of 2-(3-Amino-2,4-dioxo-5-pyrimidin-2-yl-2,3,4,5-tetrahydro-benzo [b] [1,4]diazepine-1-yl)-N-isopropyl-N-(4-methoxy-phenyl)-acetamide (933 mg, 1.97 mmol) in DMF (20 mL) were added indole-2-carboxylic acid (333 mg, 2.07 mmol), N-hydroxybenzotriazole (266 mg, 1.97 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (415 mg, 2.16 mmol) successively with stirring at ambient temperature. The resultant mixture was stirred at ambient temperature for 18 hours. The solvent was evaporated under reduced pressure to give a yellow oil which was dissolved in ethyl acetate (100 mL), washed with water (2×30 mL), dried over MgSO4, filtered and concentrated under reduced pressure to a give a tan foam. The crude product was purified by flash chromatography on silica gel (30 g) eluting with ethyl acetate (600 mL). Appropriate fractions were combined and concentrated in vacuo to give the title compound (902 mg, 1.46 mmol) as a white foam: 1H NMR (CDCl3, 400 MHz): 9.44 (s 1H), 8.75 (d, 2H, J=4.4 Hz), 7.64-6.88 (m,15H), 5.60 (d, 1H, J=6.8 Hz), 5.03 (m, 1H), 4.45 (d, 1H, J=16.6 Hz), 3.99 (d, 1H, J=16.6 Hz), 3.81 (s, 3H), 1.07 (m, 6H); TLC (CH2Cl2 /CH3OH (19:1)): Rf =0.63; MS (FAB) m/z 618.2 (MH+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05739129 |
|---|
| Source dataset | uspto-grants-1998_04 |
|---|
| ORD ID | ord-47eea2bb7ae24ad389cf6ad9b09b38d4 |
|---|
| Source note | uspto-grants-1998_04 |
|---|